Bromine in PDB 5q00: Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide
Enzymatic activity of Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide
All present enzymatic activity of Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide:
3.1.3.11;
Protein crystallography data
The structure of Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide, PDB code: 5q00
was solved by
A.Ruf,
C.Joseph,
A.Alker,
D.Banner,
T.Tetaz,
J.Benz,
B.Kuhn,
M.G.Rudolph,
H.Yang,
C.Shao,
S.K.Burley,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
29.77 /
2.60
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
66.010,
286.622,
83.524,
90.00,
97.39,
90.00
|
R / Rfree (%)
|
18.1 /
25.7
|
Bromine Binding Sites:
The binding sites of Bromine atom in the Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide
(pdb code 5q00). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 8 binding sites of Bromine where determined in the
Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide, PDB code: 5q00:
Jump to Bromine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Bromine binding site 1 out
of 8 in 5q00
Go back to
Bromine Binding Sites List in 5q00
Bromine binding site 1 out
of 8 in the Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br401
b:80.4
occ:0.48
|
BR22
|
A:95D401
|
0.0
|
80.4
|
0.5
|
C13
|
A:95D401
|
1.9
|
94.2
|
1.0
|
C14
|
A:95D401
|
2.9
|
93.6
|
1.0
|
S8
|
A:95D401
|
3.1
|
0.3
|
1.0
|
CG
|
A:MET18
|
3.4
|
66.9
|
1.0
|
SD
|
A:MET18
|
3.6
|
88.0
|
1.0
|
CG2
|
C:THR31
|
3.6
|
31.3
|
1.0
|
CB
|
A:MET18
|
3.6
|
49.9
|
1.0
|
O
|
C:GLY28
|
3.9
|
44.8
|
1.0
|
CA
|
C:GLY28
|
3.9
|
37.8
|
1.0
|
N12
|
A:95D401
|
4.1
|
90.8
|
1.0
|
S8
|
C:95D401
|
4.1
|
69.8
|
1.0
|
C7
|
A:95D401
|
4.2
|
93.2
|
1.0
|
C13
|
C:95D401
|
4.2
|
70.4
|
1.0
|
CB
|
C:THR31
|
4.3
|
27.2
|
1.0
|
CG
|
C:GLN32
|
4.4
|
28.4
|
1.0
|
CA
|
A:MET18
|
4.4
|
44.0
|
1.0
|
C
|
C:GLY28
|
4.4
|
38.6
|
1.0
|
BR22
|
C:95D401
|
4.5
|
62.8
|
0.5
|
CE
|
A:MET18
|
4.6
|
93.1
|
1.0
|
CG
|
A:ARG22
|
4.6
|
63.9
|
1.0
|
CD
|
A:ARG22
|
4.6
|
63.5
|
1.0
|
O
|
A:MET18
|
4.7
|
27.4
|
1.0
|
O19
|
C:95D401
|
4.7
|
92.1
|
1.0
|
CD
|
C:GLN32
|
4.8
|
48.9
|
1.0
|
C7
|
C:95D401
|
4.8
|
66.2
|
1.0
|
C14
|
C:95D401
|
4.8
|
64.8
|
1.0
|
C
|
A:MET18
|
4.9
|
41.5
|
1.0
|
N
|
C:GLN32
|
5.0
|
24.6
|
1.0
|
|
Bromine binding site 2 out
of 8 in 5q00
Go back to
Bromine Binding Sites List in 5q00
Bromine binding site 2 out
of 8 in the Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br401
b:0.2
occ:0.53
|
BR22
|
B:95D401
|
0.0
|
0.2
|
0.5
|
C13
|
B:95D401
|
1.9
|
0.5
|
1.0
|
C14
|
B:95D401
|
2.9
|
0.9
|
1.0
|
S8
|
B:95D401
|
3.1
|
0.5
|
1.0
|
CG
|
B:MET18
|
3.3
|
54.1
|
1.0
|
CB
|
B:MET18
|
3.5
|
31.2
|
1.0
|
SD
|
B:MET18
|
3.7
|
72.0
|
1.0
|
CG2
|
D:THR31
|
4.0
|
15.8
|
1.0
|
C13
|
D:95D401
|
4.0
|
82.5
|
1.0
|
CA
|
B:MET18
|
4.0
|
30.7
|
1.0
|
N12
|
B:95D401
|
4.1
|
0.3
|
1.0
|
CG
|
B:ARG22
|
4.1
|
27.9
|
1.0
|
O
|
D:GLY28
|
4.1
|
44.2
|
1.0
|
BR22
|
D:95D401
|
4.2
|
78.8
|
0.4
|
CA
|
D:GLY28
|
4.2
|
20.3
|
1.0
|
S8
|
D:95D401
|
4.2
|
83.6
|
1.0
|
CD
|
B:ARG22
|
4.2
|
39.5
|
1.0
|
C7
|
B:95D401
|
4.2
|
0.5
|
1.0
|
O
|
B:MET18
|
4.4
|
27.4
|
1.0
|
C14
|
D:95D401
|
4.5
|
76.4
|
1.0
|
CB
|
D:THR31
|
4.5
|
19.0
|
1.0
|
C
|
B:MET18
|
4.6
|
29.1
|
1.0
|
C
|
D:GLY28
|
4.7
|
36.2
|
1.0
|
CE
|
B:MET18
|
4.7
|
75.5
|
1.0
|
C7
|
D:95D401
|
4.9
|
78.6
|
1.0
|
N12
|
D:95D401
|
5.0
|
75.1
|
1.0
|
|
Bromine binding site 3 out
of 8 in 5q00
Go back to
Bromine Binding Sites List in 5q00
Bromine binding site 3 out
of 8 in the Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 3 of Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Br401
b:62.8
occ:0.46
|
BR22
|
C:95D401
|
0.0
|
62.8
|
0.5
|
C13
|
C:95D401
|
1.9
|
70.4
|
1.0
|
C14
|
C:95D401
|
2.9
|
64.8
|
1.0
|
S8
|
C:95D401
|
3.1
|
69.8
|
1.0
|
CG
|
C:MET18
|
3.5
|
59.5
|
1.0
|
SD
|
C:MET18
|
3.6
|
79.9
|
1.0
|
CB
|
C:MET18
|
3.7
|
30.6
|
1.0
|
CA
|
A:GLY28
|
3.8
|
39.4
|
1.0
|
O
|
A:GLY28
|
3.9
|
45.5
|
1.0
|
CD
|
C:ARG22
|
4.0
|
48.9
|
1.0
|
N12
|
C:95D401
|
4.1
|
57.9
|
1.0
|
C13
|
A:95D401
|
4.1
|
94.2
|
1.0
|
CG2
|
A:THR31
|
4.1
|
15.9
|
1.0
|
CG
|
C:ARG22
|
4.2
|
38.6
|
1.0
|
S8
|
A:95D401
|
4.2
|
0.3
|
1.0
|
C7
|
C:95D401
|
4.2
|
66.2
|
1.0
|
C
|
A:GLY28
|
4.3
|
40.1
|
1.0
|
CA
|
C:MET18
|
4.5
|
28.4
|
1.0
|
CG
|
A:GLN32
|
4.5
|
40.5
|
1.0
|
C14
|
A:95D401
|
4.5
|
93.6
|
1.0
|
BR22
|
A:95D401
|
4.5
|
80.4
|
0.5
|
CB
|
A:THR31
|
4.5
|
21.7
|
1.0
|
CE
|
C:MET18
|
4.6
|
75.2
|
1.0
|
C7
|
A:95D401
|
4.7
|
93.2
|
1.0
|
O19
|
A:95D401
|
4.7
|
99.4
|
1.0
|
O
|
C:MET18
|
4.7
|
37.7
|
1.0
|
N12
|
A:95D401
|
4.8
|
90.8
|
1.0
|
C
|
C:MET18
|
4.9
|
30.8
|
1.0
|
CD
|
A:GLN32
|
5.0
|
55.0
|
1.0
|
|
Bromine binding site 4 out
of 8 in 5q00
Go back to
Bromine Binding Sites List in 5q00
Bromine binding site 4 out
of 8 in the Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 4 of Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Br401
b:78.8
occ:0.42
|
BR22
|
D:95D401
|
0.0
|
78.8
|
0.4
|
C13
|
D:95D401
|
1.9
|
82.5
|
1.0
|
C14
|
D:95D401
|
2.9
|
76.4
|
1.0
|
S8
|
D:95D401
|
3.1
|
83.6
|
1.0
|
CG
|
D:MET18
|
3.5
|
49.8
|
1.0
|
CB
|
D:MET18
|
3.8
|
30.0
|
1.0
|
S8
|
B:95D401
|
3.8
|
0.5
|
1.0
|
SD
|
D:MET18
|
3.8
|
70.3
|
1.0
|
C13
|
B:95D401
|
3.9
|
0.5
|
1.0
|
CA
|
B:GLY28
|
3.9
|
36.1
|
1.0
|
O
|
B:GLY28
|
4.0
|
59.5
|
1.0
|
CG2
|
B:THR31
|
4.0
|
18.9
|
1.0
|
N12
|
D:95D401
|
4.1
|
75.1
|
1.0
|
CD
|
D:ARG22
|
4.1
|
51.8
|
1.0
|
BR22
|
B:95D401
|
4.2
|
0.2
|
0.5
|
CG
|
D:ARG22
|
4.2
|
45.6
|
1.0
|
C7
|
D:95D401
|
4.2
|
78.6
|
1.0
|
CB
|
B:THR31
|
4.4
|
20.4
|
1.0
|
CA
|
D:MET18
|
4.4
|
27.6
|
1.0
|
C
|
B:GLY28
|
4.4
|
49.0
|
1.0
|
C14
|
B:95D401
|
4.4
|
0.9
|
1.0
|
C7
|
B:95D401
|
4.5
|
0.5
|
1.0
|
O
|
D:MET18
|
4.7
|
35.6
|
1.0
|
CE
|
D:MET18
|
4.7
|
75.7
|
1.0
|
N12
|
B:95D401
|
4.8
|
0.3
|
1.0
|
C
|
D:MET18
|
5.0
|
30.2
|
1.0
|
|
Bromine binding site 5 out
of 8 in 5q00
Go back to
Bromine Binding Sites List in 5q00
Bromine binding site 5 out
of 8 in the Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 5 of Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:Br401
b:60.3
occ:0.49
|
BR22
|
E:95D401
|
0.0
|
60.3
|
0.5
|
C13
|
E:95D401
|
1.9
|
60.7
|
1.0
|
C14
|
E:95D401
|
2.9
|
57.9
|
1.0
|
S8
|
E:95D401
|
3.1
|
58.6
|
1.0
|
O
|
G:GLY28
|
3.7
|
41.9
|
1.0
|
CG2
|
G:THR31
|
3.7
|
15.9
|
1.0
|
CA
|
G:GLY28
|
3.8
|
37.5
|
1.0
|
S8
|
G:95D401
|
3.8
|
53.6
|
1.0
|
CG
|
E:MET18
|
3.8
|
53.9
|
1.0
|
CB
|
E:MET18
|
4.0
|
39.8
|
1.0
|
C13
|
G:95D401
|
4.0
|
52.0
|
1.0
|
SD
|
E:MET18
|
4.0
|
60.7
|
1.0
|
N12
|
E:95D401
|
4.1
|
59.8
|
1.0
|
CB
|
G:THR31
|
4.2
|
28.7
|
1.0
|
C
|
G:GLY28
|
4.2
|
40.6
|
1.0
|
C7
|
E:95D401
|
4.2
|
59.0
|
1.0
|
CG
|
E:ARG22
|
4.2
|
45.3
|
1.0
|
CD
|
E:ARG22
|
4.3
|
55.2
|
1.0
|
BR22
|
G:95D401
|
4.4
|
56.8
|
0.6
|
CG
|
G:GLN32
|
4.4
|
51.2
|
1.0
|
O19
|
G:95D401
|
4.5
|
63.6
|
1.0
|
C7
|
G:95D401
|
4.5
|
47.3
|
1.0
|
C14
|
G:95D401
|
4.7
|
38.8
|
1.0
|
CA
|
E:MET18
|
4.7
|
28.5
|
1.0
|
O
|
E:MET18
|
4.7
|
19.1
|
1.0
|
N12
|
G:95D401
|
4.9
|
35.0
|
1.0
|
CD
|
G:GLN32
|
4.9
|
64.1
|
1.0
|
CE
|
E:MET18
|
5.0
|
64.7
|
1.0
|
OG1
|
G:THR31
|
5.0
|
32.3
|
1.0
|
N
|
G:GLN32
|
5.0
|
24.7
|
1.0
|
|
Bromine binding site 6 out
of 8 in 5q00
Go back to
Bromine Binding Sites List in 5q00
Bromine binding site 6 out
of 8 in the Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 6 of Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
F:Br401
b:0.6
occ:0.50
|
BR22
|
F:95D401
|
0.0
|
0.6
|
0.5
|
C13
|
F:95D401
|
1.9
|
0.2
|
1.0
|
C14
|
F:95D401
|
2.9
|
0.6
|
1.0
|
S8
|
F:95D401
|
3.1
|
0.0
|
1.0
|
CG
|
F:MET18
|
3.4
|
67.8
|
1.0
|
CB
|
F:MET18
|
3.5
|
51.4
|
1.0
|
SD
|
F:MET18
|
3.7
|
79.4
|
1.0
|
C13
|
H:95D401
|
4.0
|
91.2
|
1.0
|
O
|
H:GLY28
|
4.1
|
39.7
|
1.0
|
N12
|
F:95D401
|
4.1
|
0.3
|
1.0
|
CA
|
F:MET18
|
4.1
|
42.4
|
1.0
|
CA
|
H:GLY28
|
4.2
|
36.1
|
1.0
|
C7
|
F:95D401
|
4.2
|
0.8
|
1.0
|
CG2
|
H:THR31
|
4.2
|
10.4
|
1.0
|
BR22
|
H:95D401
|
4.3
|
85.4
|
0.4
|
C14
|
H:95D401
|
4.4
|
87.1
|
1.0
|
CG
|
F:ARG22
|
4.4
|
38.5
|
1.0
|
S8
|
H:95D401
|
4.4
|
95.2
|
1.0
|
O
|
F:MET18
|
4.4
|
38.1
|
1.0
|
CD
|
F:ARG22
|
4.5
|
48.6
|
1.0
|
C
|
H:GLY28
|
4.6
|
33.2
|
1.0
|
C
|
F:MET18
|
4.6
|
35.0
|
1.0
|
CE
|
F:MET18
|
4.7
|
78.9
|
1.0
|
CB
|
H:THR31
|
4.8
|
27.3
|
1.0
|
CG
|
H:GLN32
|
4.8
|
39.9
|
1.0
|
N12
|
H:95D401
|
4.8
|
84.3
|
1.0
|
C7
|
H:95D401
|
4.9
|
88.0
|
1.0
|
CG2
|
F:THR31
|
5.0
|
21.0
|
1.0
|
|
Bromine binding site 7 out
of 8 in 5q00
Go back to
Bromine Binding Sites List in 5q00
Bromine binding site 7 out
of 8 in the Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 7 of Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
G:Br401
b:56.8
occ:0.57
|
BR22
|
G:95D401
|
0.0
|
56.8
|
0.6
|
C13
|
G:95D401
|
1.9
|
52.0
|
1.0
|
C14
|
G:95D401
|
2.9
|
38.8
|
1.0
|
S8
|
G:95D401
|
3.1
|
53.6
|
1.0
|
CG
|
G:MET18
|
3.4
|
45.5
|
1.0
|
SD
|
G:MET18
|
3.6
|
58.0
|
1.0
|
CB
|
G:MET18
|
3.6
|
39.8
|
1.0
|
CG2
|
E:THR31
|
3.6
|
24.7
|
1.0
|
S8
|
E:95D401
|
3.9
|
58.6
|
1.0
|
O
|
E:GLY28
|
4.0
|
43.1
|
1.0
|
C13
|
E:95D401
|
4.1
|
60.7
|
1.0
|
N12
|
G:95D401
|
4.1
|
35.0
|
1.0
|
CA
|
E:GLY28
|
4.2
|
41.6
|
1.0
|
CB
|
E:THR31
|
4.2
|
28.1
|
1.0
|
C7
|
G:95D401
|
4.2
|
47.3
|
1.0
|
CA
|
G:MET18
|
4.3
|
41.5
|
1.0
|
BR22
|
E:95D401
|
4.4
|
60.3
|
0.5
|
CG
|
E:GLN32
|
4.5
|
36.4
|
1.0
|
CG
|
G:ARG22
|
4.5
|
47.2
|
1.0
|
C7
|
E:95D401
|
4.6
|
59.0
|
1.0
|
CE
|
G:MET18
|
4.6
|
61.4
|
1.0
|
C
|
E:GLY28
|
4.6
|
42.3
|
1.0
|
C14
|
E:95D401
|
4.6
|
57.9
|
1.0
|
CD
|
G:ARG22
|
4.7
|
57.6
|
1.0
|
O
|
G:MET18
|
4.7
|
41.1
|
1.0
|
O19
|
E:95D401
|
4.7
|
63.6
|
1.0
|
C
|
G:MET18
|
4.8
|
37.8
|
1.0
|
CD
|
E:GLN32
|
4.9
|
55.1
|
1.0
|
N12
|
E:95D401
|
4.9
|
59.8
|
1.0
|
|
Bromine binding site 8 out
of 8 in 5q00
Go back to
Bromine Binding Sites List in 5q00
Bromine binding site 8 out
of 8 in the Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 8 of Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl)Carbamoylsulfamoyl]-1-Methylindol-7- Yl]Oxyacetamide within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Br401
b:85.4
occ:0.40
|
BR22
|
H:95D401
|
0.0
|
85.4
|
0.4
|
C13
|
H:95D401
|
1.9
|
91.2
|
1.0
|
C14
|
H:95D401
|
2.9
|
87.1
|
1.0
|
S8
|
H:95D401
|
3.1
|
95.2
|
1.0
|
CG
|
H:MET18
|
3.7
|
67.1
|
1.0
|
CB
|
H:MET18
|
3.8
|
45.2
|
1.0
|
SD
|
H:MET18
|
3.8
|
81.7
|
1.0
|
CA
|
F:GLY28
|
3.8
|
48.6
|
1.0
|
O
|
F:GLY28
|
3.8
|
34.8
|
1.0
|
S8
|
F:95D401
|
3.8
|
0.0
|
1.0
|
CG2
|
F:THR31
|
3.9
|
21.0
|
1.0
|
C13
|
F:95D401
|
4.0
|
0.2
|
1.0
|
CG
|
H:ARG22
|
4.1
|
67.0
|
1.0
|
N12
|
H:95D401
|
4.1
|
84.3
|
1.0
|
CD
|
H:ARG22
|
4.1
|
69.5
|
1.0
|
CB
|
F:THR31
|
4.2
|
26.2
|
1.0
|
C7
|
H:95D401
|
4.2
|
88.0
|
1.0
|
C
|
F:GLY28
|
4.3
|
44.7
|
1.0
|
BR22
|
F:95D401
|
4.3
|
0.6
|
0.5
|
CA
|
H:MET18
|
4.5
|
35.9
|
1.0
|
C7
|
F:95D401
|
4.7
|
0.8
|
1.0
|
C14
|
F:95D401
|
4.7
|
0.6
|
1.0
|
O
|
H:MET18
|
4.7
|
49.7
|
1.0
|
CG
|
F:GLN32
|
4.7
|
52.0
|
1.0
|
CE
|
H:MET18
|
4.8
|
80.1
|
1.0
|
OG1
|
F:THR31
|
5.0
|
24.7
|
1.0
|
C
|
H:MET18
|
5.0
|
40.5
|
1.0
|
|
Reference:
A.Ruf,
C.Joseph,
A.Alker,
D.Banner,
T.Tetaz,
J.Benz,
B.Kuhn,
M.G.Rudolph.
Human Liver Fructose-1,6-Bisphosphatase 1 (Fructose 1,6-Bisphosphate 1-Phosphatase, E.C.3.1.3.11) Complexed with the Allosteric Inhibitor 2-[3-[(5-Bromo-1,3-Thiazol-2-Yl) Carbamoylsulfamoyl]-1-Methylindol-7-Yl]Oxyacetamide To Be Published.
Page generated: Thu Jul 11 00:41:07 2024
|